1-7 of 7
serum total protein measurement
Close
Sort by
Journal Articles

The Gamma Gap: A Point-of-Care Test That Correlates with Disease Burden and Treatment Response in Multiple Myeloma

Megan Murray Dupuis, MD PhD, Zhiguo Li, PhD, Sascha A Tuchman, MD, Yubin Kang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4407.
https://doi.org/10.1182/blood.V130.Suppl_1.4407.4407
Published: 2017
Journal Articles

Longitudinal Evaluation of Renal Function in Multiple Myeloma

Marlies Antlanger, Thomas Reiter, MD, Eleonore Pablik, Christoph Minichsdorfer, Edit Porpaczy, MD, Susanne Rasoul-Rockenschaub, Heinz Gisslinger, Hermine Agis, MD, Maria-Theresa Krauth, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5387.
https://doi.org/10.1182/blood.V130.Suppl_1.5387.5387
Published: 2017
Journal Articles

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Jingjing Wang, Mei Dong, MD, Xiaohui He, MD, Weihu Wang, MD, Peng Liu, MD, Jianliang Yang, MD, Yan Qin, MD, Lin Gui, MD, Sheng Yang, MD, Yexiong Li, MD PhD, Yuankai Shi, MD PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 3071.
https://doi.org/10.1182/blood.V124.21.3071.3071
Published: 2014
Journal Articles

Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien

Stefan F Cordes, MD, PhD, Morie A Gertz, M.D., Francis K Buadi, MD, Yi Lin, MDPhD, Martha Q Lacy, MD, Prashant Kapoor, MD, Shaji K Kumar, MD, Arleigh McCurdy, MD, Angela Dispenzieri, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, William J. Hogan, MBChB, Rajiv K Pruthi, MBBS
Journal: Blood
Blood (2013) 122 (21): 2151.
https://doi.org/10.1182/blood.V122.21.2151.2151
Published: 2013
Journal Articles

Pre-Transplant Weight Loss and Total Serum Protein Predict Relapse Of Acute Myeloid Leukaemia After Allogeneic Stem Cell Transplantation

Thomas Luft, MD, PhD, Sascha Dietrich, MD, Aleksandar Radujkovic, MD, Friedrich Stölzel, MD, Christine Falk, Axel Benner, Markus Schaich, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Alwin Kraemer, MD, Ute Hegenbart, MD, Anthony D Ho, MD, Peter Dreger, MD
Journal: Blood
Blood (2013) 122 (21): 3314.
https://doi.org/10.1182/blood.V122.21.3314.3314
Published: 2013
Journal Articles

N-Methyl-2-Pyrrolidone Is a Biologically Active Thalidomide Subunit with In Vivo anti-Myeloma Properties

Jake Shortt, FRACP, FRCPA, Andy Hsu, PhD, Geoffrey M Matthews, PhD, Marta Chesi, P.Leif Bergsagel, MD, Grant A. McArthur, MD, PhD, FRACP, MBBS, Paul Neeson, PhD, David Ritchie, MBBS, FRACP, FRCPA, Ricky W Johnstone, PhD
Journal: Blood
Blood (2010) 116 (21): 4082.
https://doi.org/10.1182/blood.V116.21.4082.4082
Published: 2010
Journal Articles

Use of Patient-Reported Outcomes (PROs) to Assess Prognosis, Toxicity, and Response: The Bortezomib Experience in Relapsed and Refractory Multiple Myeloma (MM).

Dominique Dubois, Dhawan Ravinder, Helgi van de Velde, Dixie Esseltine, Sanjay Gupta, Muriel Viala, Christine de la Loge
Journal: Blood
Blood (2004) 104 (11): 3468.
https://doi.org/10.1182/blood.V104.11.3468.3468
Published: 2004